Vietnam – where rapid economic growth meets ambitious healthcare system transformation plans – is one of the key directions in Adamed’s international development strategy.

Last week, Małgorzata Adamkiewicz, MD, PhD, President of the Supervisory Board and Co-owner of Adamed Pharma, visited the Davipharm manufacturing site in Binh Duong (Ho Chi Minh City).

Davipharm, a member of the Adamed Group, is one of the fastest-growing pharmaceutical companies in Vietnam and represents the largest Polish private investment in the country.

The visit was an excellent opportunity to discuss the expansion of the production site, technology transfer, and future development plans of the Adamed Group in Asia with Mr. Michał Wieczorek, General Director of Davipharm.